galactose has been researched along with tacrolimus in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benndorf, R; Greenbaum, LA; Smoyer, WE | 1 |
Desai, JL; Mistry, NP; Thakkar, HP | 1 |
Barratt, J; Kim, MJ; Koller, MT; Molyneux, K; Schaub, S; Stampf, S | 1 |
Ishchenko, AV; Shakhnovich, EI | 1 |
1 review(s) available for galactose and tacrolimus
Article | Year |
---|---|
Childhood nephrotic syndrome--current and future therapies.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Child; Cyclophosphamide; Cyclosporine; Enzyme Inhibitors; Galactose; Glucocorticoids; Homeostasis; Humans; Immunologic Factors; Immunosuppressive Agents; Interleukin-13; Intracellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Mycophenolic Acid; Nephrotic Syndrome; p38 Mitogen-Activated Protein Kinases; Plasmapheresis; Protein Serine-Threonine Kinases; Receptors, Notch; Ribonucleosides; Rituximab; Signal Transduction; Tacrolimus; Thiazolidinediones; Unfolded Protein Response | 2012 |
3 other study(ies) available for galactose and tacrolimus
Article | Year |
---|---|
Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
Topics: Animals; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Galactose; Immunosuppressive Agents; Lactic Acid; Liver; Magnetic Resonance Spectroscopy; Male; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Tacrolimus; Tissue Distribution | 2015 |
Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy.
Topics: Antibodies, Monoclonal; Basiliximab; Drug Therapy, Combination; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunoglobulin G; Immunosuppressive Agents; Kidney; Male; Middle Aged; Mycophenolic Acid; Prednisone; Recombinant Fusion Proteins; Sirolimus; Tacrolimus | 2016 |
SMall Molecule Growth 2001 (SMoG2001): an improved knowledge-based scoring function for protein-ligand interactions.
Topics: Carbonic Anhydrases; Computing Methodologies; Databases, Factual; Ligands; Metalloendopeptidases; Metals; Molecular Conformation; Protein Binding; Proteins; Quantitative Structure-Activity Relationship; Statistics as Topic; Thermodynamics | 2002 |